142 related articles for article (PubMed ID: 35906150)
1. [Immune-related pneumonitis: A differential diagnosis of SARS-CoV-2 pneumonia].
Nigen B; Chéné AL; Liberge R; Sagan C; Blanc FX
Rev Mal Respir; 2022 Sep; 39(7):626-632. PubMed ID: 35906150
[TBL] [Abstract][Full Text] [Related]
2. Safety of current immune checkpoint inhibitors in non-small cell lung cancer.
Abdayem P; Planchard D
Expert Opin Drug Saf; 2021 Jun; 20(6):651-667. PubMed ID: 33393387
[No Abstract] [Full Text] [Related]
3. COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.
Dipasquale A; Persico P; Lorenzi E; Rahal D; Santoro A; Simonelli M
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574054
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19.
Mellinghoff SC; Vanshylla K; Dahlke C; Addo MM; Cornely OA; Klein F; Persigehl T; Rybniker J; Gruell H; Bröckelmann PJ
Front Immunol; 2021; 12():798276. PubMed ID: 34987520
[TBL] [Abstract][Full Text] [Related]
5. Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.
Rossi E; Schinzari G; Tortora G
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699182
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.
Catania C; Stati V; Spitaleri G
Tumori; 2021 Jun; 107(3):267-269. PubMed ID: 32842909
[TBL] [Abstract][Full Text] [Related]
7. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.
Abid MB
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931473
[TBL] [Abstract][Full Text] [Related]
8. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.
Dai Y; Liu S; Zhang Y; Li X; Zhao Z; Liu P; Du Y
J Med Case Rep; 2021 Feb; 15(1):41. PubMed ID: 33522942
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Toxicities of Immunotherapy.
Altan M; Zhong L; Shannon VR; Sheshadri A
Adv Exp Med Biol; 2021; 1342():357-375. PubMed ID: 34972974
[TBL] [Abstract][Full Text] [Related]
10. Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases demonstrating a good response to high-dose corticosteroid therapy.
Uemasu K; Yasuda Y; Hirayama Y; Arasawa S; Iwashima D; Takahashi KI
J Infect Chemother; 2022 Feb; 28(2):321-325. PubMed ID: 34810106
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR
J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Pneumonia and Lung Cancer: A Challenge for the RadiologistReview of the Main Radiological Features, Differential Diagnosis and Overlapping Pathologies.
Guarnera A; Santini E; Podda P
Tomography; 2022 Feb; 8(1):513-528. PubMed ID: 35202206
[TBL] [Abstract][Full Text] [Related]
13. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular, Renal and Pulmonary Toxicity of Immune Checkpoint Inhibitors in Cancer: What the GP Should Know.
Smekens L; Genoud V; Usdin N; Ben Aïssa A
Praxis (Bern 1994); 2023; 112(3):160-171. PubMed ID: 36855889
[No Abstract] [Full Text] [Related]
15. [Consortium for detection and management of lung damage induced by bleomycin].
Biya J; Stoclin A; Dury S; Le Pavec J; Mir O; Lazarovici J; Fermé C; Annereau M; Ekpe K; Massard C; Michot JM
Bull Cancer; 2016; 103(7-8):651-61. PubMed ID: 27241272
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.
Ata F; Shaher Mousa Hussein M; Mismar AY; Sharma R; Bozom IAM; Alsiddig Ali Ibrahim Z; Ibrahim WH
Am J Case Rep; 2020 Aug; 21():e927586. PubMed ID: 32840240
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.
Asher N; Marom EM; Ben-Betzalel G; Baruch EN; Steinberg-Silman Y; Schachter J; Shapira-Frommer R; Markel G
Oncologist; 2019 May; 24(5):640-647. PubMed ID: 30777894
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung Cancer.
Naidoo J; Nishino M; Patel SP; Shankar B; Rekhtman N; Illei P; Camus P
Clin Lung Cancer; 2020 Sep; 21(5):e435-e444. PubMed ID: 32576443
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
Bersanelli M; Zielli T; Perrone F; Casartelli C; Pratticò F; Rapacchi E; Camisa R; Tognetto M; Clemente A; Giannarelli D; Rebuzzi SE; Leonetti A; Bordi P; Tiseo M; Buti S
Immunotherapy; 2020 Oct; 12(15):1139-1148. PubMed ID: 32933369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
